As shown in Table 2, participants with obesity, and diabetes were exposed to a high cardiometabolic risk, illustrated by insulin resistance (high insulin and HOMA-IR index values), glucose intolerance (a rise in HbA1c levels), and dyslipidemia. This evidence concerns the gene INS and obesity disorder.